Ultrasound in Medicine and Biology
Volume 35, Issue 9 , Pages 1427-1435 , September 2009

Hepatic Transit Time Analysis Using Contrast-Enhanced Ultrasound with BR1: A Prospective Study Comparing Patients with Liver Metastases from Colorectal Cancer with Healthy Volunteers

  • Joachim Hohmann

      Affiliations

    • Department of Radiology, University Hospital Basel, Basel, Switzerland
    • Corresponding Author InformationAddress correspondence to: Joachim Hohmann, MD, Department of Radiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
    • ,
  • Christine Müller

      Affiliations

    • Department of Radiology and Nuclear Medicine, Charité Campus Benjamin Franklin, Berlin, Germany
    • ,
  • Anja Oldenburg

      Affiliations

    • Department of Radiology and Nuclear Medicine, Charité Campus Benjamin Franklin, Berlin, Germany
    • ,
  • Jan Skrok

      Affiliations

    • Department of Radiology and Nuclear Medicine, Charité Campus Benjamin Franklin, Berlin, Germany
    • ,
  • Bernd B. Frericks

      Affiliations

    • Department of Radiology and Nuclear Medicine, Charité Campus Benjamin Franklin, Berlin, Germany
    • ,
  • Karl-Jürgen Wolf

      Affiliations

    • Department of Radiology and Nuclear Medicine, Charité Campus Benjamin Franklin, Berlin, Germany
    • ,
  • Thomas Albrecht

      Affiliations

    • Department of Radiology and Nuclear Medicine, Charité Campus Benjamin Franklin, Berlin, Germany

Received 11 August 2008 ,Revised 24 March 2009 ,Accepted 8 April 2009.

References 

  1. Albrecht T, Blomley MJ, Cosgrove DO, Taylor-Robinson SD, Jayaram V, Eckersley R, et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet. 1999;353(9164):1579–1583
  2. Ballantyne KC, Charnley RM, Perkins AC, Pye G, Whalley DR, Wastie ML, et al. Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer. Nucl Med Commun. 1990;11(1):23–28
  3. Bang N, Nielsen MB, Rasmussen AN, Osterhammel PA, Pedersen JF. Hepatic vein transit time of an ultrasound contrast agent: Simplified procedure using pulse inversion imaging. Br J Radiol. 2001;74(884):752–755
  4. Bernatik T, Becker D, Neureiter D, Hansler JH, Frieser M, Schaber S, et al. Hepatic transit time of an echo enhancer: An indicator of metastatic spread to the liver. Eur J Gastroenterol Hepatol. 2004;16(3):313–317
  5. Blomley MJ, Albrecht T, Cosgrove DO, Jayaram V, Eckersley RJ, Patel N, et al. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology. 1998;209(3):862–866
  6. Blomley MJ, Coulden R, Dawson P, Kormano M, Donlan P, Bufkin C, et al. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr. 1995;19(3):424–433
  7. Cleveland WS, Devlin SJ. Locally weighted regression: An approach to regression analysis by local fitting. J Am Stat Assoc. 1988;83:596–610
  8. Cooke DA, Parkin A, Wiggins P, Robinson PJ, Giles GR. Hepatic perfusion index and the evolution of liver metastases. Nucl Med Commun. 1987;8(12):970–972
  9. Fong Y. Doppler perfusion index in colorectal cancer. Lancet. 2000;355(9197):5–6
  10. Fowler RC, Harris KM, Swift SE, Ward M, Greenwood DC. Hepatic Doppler perfusion index: measurement in nine healthy volunteers. Radiology. 1998;209(3):867–871
  11. Glover C, Douse P, Kane P, Karani J, Meire H, Mohammadtaghi S, et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum. 2002;45(4):476–484
  12. Goldberg JA, Bessent RG, McArdle CS, McKillop JH. Detection of occult hepatic metastases using the hepatic perfusion index. Is the hepatic perfusion index clinically useful?. Nucl Med Commun. 1991;12(2):158–162
  13. Kruskal JB, Thomas P, Kane RA, Goldberg SN. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology. 2004;231(2):482–490
  14. Leen E. The detection of occult liver metastases of colorectal carcinoma. J Hepat Pancreatic Surg. 1999;6(1):7–15
  15. Leen E, Angerson WG, Cooke TG, McArdle CS. Prognostic power of Doppler perfusion index in colorectal cancer. Correlation with survival. Ann Surg. 1996;223(2):199–203
  16. Leen E, Angerson WJ, Wotherspoon H, Moule B, Cook TG, McArdle CS. Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. Radiology. 1995;195(1):113–116
  17. Leen E, Goldberg JA, Angerson WJ, McArdle CS. Potential role of Doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet. 2000;355(9197):34–37
  18. Leveson SH, Wiggins PA, Giles GR, Parkin A, Robinson PJ. Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg. 1985;72(2):128–130
  19. Lim AK, Patel N, Eckersley RJ, Goldin RD, Thomas HC, Cosgrove DO, et al. Hepatic vein transit time of SonoVue: A comparative study with Levovist. Radiology. 2006;240(1):130–135
  20. Lim AK, Taylor-Robinson SD, Patel N, Eckersley RJ, Goldin RD, Hamilton G, et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut. 2005;54(1):128–133
  21. Materne R, Smith AM, Peeters F, Dehoux JP, Keyeux A, Horsmans Y, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med. 2002;47(1):135–142
  22. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology. 1993;188(2):405–411
  23. Nott DM, Grime SJ, Yates J, Day DW, Baxter JN, Jenkins SA, et al. Changes in the hepatic perfusion index during the development of experimental hepatic tumours. Br J Surg. 1989;76(3):259–263
  24. Ong KO, Leen E. Radiological staging of colorectal liver metastases. Surg Oncol. 2007;16(1):7–14
  25. Perkins AC, Whalley DR, Ballantyne KC, Hardcastle JD. Reliability of the hepatic perfusion index for the detection of liver metastases. Nucl Med Commun. 1987;8(12):982–989
  26. Ridge JA, Bading JR, Gelbard AS, Benua RS, Daly JM. Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer. 1987;59(9):1547–1553
  27. Robinson PJ, Parkin A. Detection of occult hepatic metastases using the hepatic perfusion index. Nucl Med Commun. 1991;12(2):153–158
  28. Roumen RM, Scheltinga MR, Slooter GD, van der Linden AW. Doppler perfusion index fails to predict the presence of occult hepatic colorectal metastases. Eur J Surg Oncol. 2005;31(5):521–527
  29. Shi GF, Wang SJ, Wang Q, Xu Q, Li RX, Du Y, et al. [Effect of perfusion CT scan on hepatic hemodynamic changes in rats with liver micrometastases]. Ai Zheng. 2006;25(7):849–854
  30. Sugimoto H, Kaneko T, Hirota M, Tezel E, Nakao A. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. J Hepatol. 2002;37(5):578–583
  31. Totman JJ, O'Gorman RL, Kane PA, Karani JB. Comparison of the hepatic perfusion index measured with gadolinium-enhanced volumetric MRI in controls and in patients with colorectal cancer. Br J Radiol. 2005;78(926):105–109
  32. Warren HW, Angerson WJ, Leen E, Carter R, McArdle CS, Cooke TJ. Haemodynamic changes associated with colorectal liver metastases: Evidence of a humoral mediator (abstr). Br J Surg. 1993;80:1461
  33. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol. 2007;33(2):318–325
  34. Yarmenitis SD, Kalogeropoulou CP, Hatjikondi O, Ravazoula P, Petsas T, Siamblis D, et al. An experimental approach of the Doppler perfusion index of the liver in detecting occult hepatic metastases: Histological findings related to the hemodynamic measurements in Wistar rats. Eur Radiol. 2000;10(3):417–424

PII: S0301-5629(09)00157-4

doi: 10.1016/j.ultrasmedbio.2009.04.002

Ultrasound in Medicine and Biology
Volume 35, Issue 9 , Pages 1427-1435 , September 2009

Article Tools

* Image Usage & Resolution